RIG
28
-3
SE
86
-2
AAP
47
-3
EQIX
67
2
CI
42
-3
SPG
51
3
TSCO
51
-4
EMR
51
-5
KO
55
-8
TROW
29
-3
CMCSA
42
-4
PFE
39
-7
MTB
64
-4
AKAM
37
-2
XOM
40
-4
XRX
28
-2
FMC
34
4
ADM
33
-3
DAL
61
-3
TJX
51
-3
RIG
28
-3
SE
86
-2
AAP
47
-3
EQIX
67
2
CI
42
-3
SPG
51
3
TSCO
51
-4
EMR
51
-5
KO
55
-8
TROW
29
-3
CMCSA
42
-4
PFE
39
-7
MTB
64
-4
AKAM
37
-2
XOM
40
-4
XRX
28
-2
FMC
34
4
ADM
33
-3
DAL
61
-3
TJX
51
-3
Financhill
Back

Esquire Financial Holdings Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
69

ESQ
Esquire Financial Holdings

Last Price:
$90.81
Seasonality Move:
10.31%
Sell
34

APLS
Apellis Pharmaceuticals

Last Price:
$17.40
Seasonality Move:
0.23%
Buy
69
Esquire Financial Holdings (ESQ) is a Buy

Is Esquire Financial Holdings a Buy, Sell or Hold?

  • The current Esquire Financial Holdings [ESQ] share price is $89.38. The Score for ESQ is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
  • ESQ is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $17.41. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ESQ Stock Price Chart

What is Esquire Financial Holdings's stock price today?

  • The Esquire Financial Holdings share price today is $89.38
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ESQ is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $17.41
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

ESQ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.06 Buy
Relative Strength Index (14 RSI): 58.23 Buy
Chaikin Money Flow: 9900 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.65 Sell
Relative Strength Index (14 RSI): 44.4 Sell
Chaikin Money Flow: 1588413 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.89 - 18.97) Sell
Bollinger Bands (100): (18.81 - 29.13) Sell

ESQ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 90.1 Sell
20-day SMA: 88.71 Buy
50-day SMA: 81.89 Buy
200-day SMA: 74.27 Buy
8-day EMA: 89.72 Sell
20-day EMA: 87.59 Buy
50-day EMA: 72.92 Buy
200-day EMA: 31.69 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.49 Sell
20-day SMA: 17.89 Sell
50-day SMA: 19.51 Sell
200-day SMA: 28.26 Sell
8-day EMA: 17.33 Buy
20-day EMA: 17.78 Sell
50-day EMA: 19.75 Sell
200-day EMA: 28.32 Sell

Esquire Financial Holdings Earnings Growth & ESQ Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.07 per share, an increase this year of $0.40 per share, and an increase next year of $0.53 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.19 per share, and an increase next year of $1.21 per share.

Esquire Financial Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):